OLBA HEALTHCARE HOLDINGS, Inc. (TYO:2689)
Japan · Delayed Price · Currency is JPY 1,877.00
+2.00 (0.11%)
Aug 26, 2026, 10:37 AM JST
OLBA HEALTHCARE HOLDINGS Income Statement
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 126,595 | 122,702 | 118,564 | 110,472 | 107,959 | |
Revenue Growth | 3.17% | 3.49% | 7.32% | 2.33% | -4.44% |
Cost of Revenue | 112,417 | 108,793 | 104,964 | 97,518 | 95,456 |
Gross Profit | 14,178 | 13,909 | 13,600 | 12,954 | 12,503 |
Selling, General & Admin | 12,482 | 11,929 | 11,365 | 10,794 | 10,430 |
Operating Expenses | 12,498 | 11,929 | 11,374 | 10,810 | 10,430 |
Operating Income | 1,680 | 1,980 | 2,226 | 2,144 | 2,073 |
Interest Expense | -60 | -37 | -19 | -17 | -20 |
Interest & Investment Income | 5 | 7 | 6 | 2 | 2 |
Earnings From Equity Investments | - | - | - | - | 26 |
Currency Exchange Gain (Loss) | 16 | 3 | 7 | - | - |
Other Non Operating Income (Expenses) | 22 | 9 | 23 | 29 | 38 |
EBT Excluding Unusual Items | 1,663 | 1,962 | 2,243 | 2,158 | 2,119 |
Gain (Loss) on Sale of Investments | - | -19 | - | - | 12 |
Gain (Loss) on Sale of Assets | 113 | 1 | 1 | 1 | 27 |
Asset Writedown | -2 | -29 | -2 | -2 | -124 |
Other Unusual Items | - | 4 | - | -1 | 102 |
Pretax Income | 1,774 | 1,919 | 2,242 | 2,156 | 2,136 |
Income Tax Expense | 662 | 489 | 742 | 742 | 601 |
Earnings From Continuing Operations | 1,112 | 1,430 | 1,500 | 1,414 | 1,535 |
Net Income | 1,112 | 1,430 | 1,500 | 1,414 | 1,535 |
Net Income to Common | 1,112 | 1,430 | 1,500 | 1,414 | 1,535 |
Net Income Growth | -22.24% | -4.67% | 6.08% | -7.88% | 55.21% |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 |
Shares Change | 0.07% | -0.64% | -0.98% | -0.87% | -0.15% |
EPS (Basic) | 187.60 | 241.41 | 251.62 | 234.86 | 252.75 |
EPS (Diluted) | 187.60 | 241.41 | 251.62 | 234.86 | 252.75 |
EPS Growth | -22.29% | -4.06% | 7.13% | -7.08% | 55.44% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -389 | 181 | 1,733 | -820 | 2,123 |
Free Cash Flow Per Share | -65.63 | 30.56 | 290.70 | -136.20 | 349.57 |
Dividend Per Share | - | 80.000 | 80.000 | 70.000 | 60.000 |
Dividend Growth | - | 0% | 14.29% | 16.67% | 33.33% |
Gross Margin | 11.20% | 11.34% | 11.47% | 11.73% | 11.58% |
Operating Margin | 1.33% | 1.61% | 1.88% | 1.94% | 1.92% |
Profit Margin | 0.88% | 1.17% | 1.26% | 1.28% | 1.42% |
Free Cash Flow Margin | -0.31% | 0.15% | 1.46% | -0.74% | 1.97% |
EBITDA | 2,423 | 2,615 | 2,790 | 2,653 | 2,476 |
EBITDA Margin | 1.91% | 2.13% | 2.35% | 2.40% | 2.29% |
D&A For EBITDA | 743 | 635 | 564 | 509 | 403 |
EBIT | 1,680 | 1,980 | 2,226 | 2,144 | 2,073 |
EBIT Margin | 1.33% | 1.61% | 1.88% | 1.94% | 1.92% |
Effective Tax Rate | 37.32% | 25.48% | 33.09% | 34.42% | 28.14% |